Yann Bergé
Yann Bergé publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies and Lung Cancer Treatments and Mutations.
- World rank
- #3,818,472 of 7,710,434 ranked researchers
- Rank in France
- #160,813 of 324,115
- Works
- 33
- Citations
- 412
- Citations per work
- 12.5
What does Yann Bergé research?
Yann Bergé's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (24%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1853.9%
- Medicine1853.9%
- Life Sciences823.6%
- Everything else722.5%
- 1Oncology29% of their works
- 2Molecular Biology20% of their works
- 3Pulmonary and Respiratory Medicine13% of their works
- 4Radiology, Nuclear Medicine and Imaging8% of their works
- 5Surgery4% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe Yann Bergé's research?
The keywords of their largest research topics: Chemotherapy, Breast Cancer, HER2, Trastuzumab, Cetuximab, EGFR Mutations, KRAS Mutations and Targeted Therapy.
- Receptor
- Soft Tissue Sarcoma
- Osteosarcoma
- Therapeutic Antibodies
- Fc Receptors
- Targeted Therapy
- EGFR Mutations
- Trastuzumab
- Breast Cancer
- Chemotherapy
- HER2
- Cetuximab
- KRAS Mutations
- Chemotherapy-Induced Peripheral Neuropathy
- Taxanes
- Molecular Chaperones
- Protein Folding
- Estrogen
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Chemotherapy163 topics
- Breast Cancer102 topics
- HER281 topic
- Trastuzumab81 topic
- Cetuximab51 topic
- EGFR Mutations51 topic
- KRAS Mutations51 topic
- Targeted Therapy51 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Fc Receptors41 topic
- Taxanes41 topic
- Therapeutic Antibodies41 topic
- Molecular Chaperones31 topic
- Osteosarcoma31 topic
- Protein Folding31 topic
- Soft Tissue Sarcoma31 topic
- Estrogen21 topic
- Receptor21 topic
Where does Yann Bergé work?
Yann Bergé's main affiliation in the publication record is Institut Claudius Regaud, France.
How many publications and citations does Yann Bergé have?
OpenAlex counts 33 works and 412 citations for Yann Bergé, an h-index of 11, ranking #3,818,472 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yann Bergé. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.